Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zeprumetostat, Azacitidine, and Mitoxantrone Hydrochloride Liposome in Relapsed/Refractory PTCL
NCT07372352Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zeprumetostat in peripheral T-cell lymphoma (PTCL), sponsored by First Affiliated Hospital of Soochow University. Started Jan 2026; status: recruiting.
02
Drugs
zeprumetostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT07372352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07372352.